# Azora Therapeutics, Inc. — Form D

Azora Therapeutics, Inc. of Encino, CA, a company, filed a Form D exempt-offering notice with the SEC on 2021-06-14. The offering totals $8.4M, of which $7.7M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2021-06-14
- Form: D
- Accession: 0001567619-21-012036
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $8.4M
- Amount sold: $7.7M
- Remaining: $625K
- Investors: 108
- Date of first sale: 2021-06-01
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-402715

## Issuer

- Name: Azora Therapeutics, Inc.
- CIK: 0001866534
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 4267 Valley Meadow Road, Encino, CA, 91436
- Phone: (818) 276-6726

## Officers, directors & promoters (7)

| Name | Role | Location |
| --- | --- | --- |
| Matt Davidson | Director | Encino, CA |
| Matt Davidson | Executive Officer | Encino, CA |
| Dennis Brown | Director | New York, NY |
| Julie Saiki | Director | Encino, CA |
| Julie Saiki | Executive Officer | Encino, CA |
| Matthew Davidson | Director | Encino, CA |
| Matthew Davidson | Executive Officer | Encino, CA |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2023-08-09](https://search.stillhousedata.com/formd/0001567619-23-006844) | D | $596K | $581K |

## More

- [CIK 1866534 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1866534&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001567619-21-012036.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.